Gene · 11255
Papers1,482
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,482
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms of abnormal adult hippocampal neurogenesis in Alzheimer's disease. | Front Neurosci | 2023 | 36875663 | PubTator, text mining | PubMed |
| Lysosomal phospholipase A2 contributes to the biosynthesis of the atypical late endosome lipid bis(monoacylglycero)phosphate. | Commun Biol | 2023 | 36823305 | PubTator, text mining | PubMed |
| Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer's disease. | J Enzyme Inhib Med Chem | 2023 | 36789662 | PubTator, text mining | PubMed |
| Follicular Thyroid Adenoma and Follicular Thyroid Carcinoma-A Common or Distinct Background? Loss of Heterozygosity in Comprehensive Microarray Study. | Cancers (Basel) | 2023 | 36765597 | PubTator, text mining | PubMed |
| Amyotrophic lateral sclerosis disease burden: doing better at getting better. | Neural Regen Res | 2023 | 36751796 | PubTator, text mining | PubMed |
| Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration. | Sci Rep | 2023 | 36732336 | PubTator, text mining | PubMed |
| Structural and Molecular Determinants for Isoform Bias at Human Histamine H3 Receptor Isoforms. | ACS Chem Neurosci | 2023 | 36702158 | PubTator, text mining | PubMed |
| Imidazole: Synthesis, Functionalization and Physicochemical Properties of a Privileged Structure in Medicinal Chemistry. | Molecules | 2023 | 36677894 | PubTator, text mining | PubMed |
| Drug Repurposing to Inhibit Histamine N-Methyl Transferase. | Molecules | 2023 | 36677633 | PubTator, text mining | PubMed |
| The preoperative plasma histamine level as a possible protective biomarker for postoperative acute kidney injury. | Medicine (Baltimore) | 2023 | 36607872 | PubTator, text mining | PubMed |
| Multitargeting approaches to cognitive impairment: Synthesis of aryl-alkylpiperazines and assessment at cholinesterases, histamine H3 and dopamine D3 receptors. | Bioorg Med Chem | 2023 | 36542960 | PubTator, text mining | PubMed |
| Histamine bidirectionally regulates the intrinsic excitability of parvalbumin-positive neurons in the lateral globus pallidus and promotes motor behaviour. | Br J Pharmacol | 2023 | 36512485 | PubTator, text mining | PubMed |
| Anti-inflammatory effects of new human histamine H3 receptor ligands with flavonoid structure on BV-2 neuroinflammation. | Inflamm Res | 2023 | 36370200 | PubTator, text mining | PubMed |
| SAR exploration of the non-imidazole histamine H3 receptor ligand ZEL-H16 reveals potent inverse agonism. | Arch Pharm (Weinheim) | 2023 | 36310109 | PubTator, text mining | PubMed |
| Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer. | J Cancer Res Clin Oncol | 2023 | 35751684 | PubTator, text mining | PubMed |
| What respiratory physicians should know about narcolepsy and other hypersomnias. | Breathe (Sheff) | 2022 | 36865656 | PubTator, text mining | PubMed |
| Benzophenone Derivatives with Histamine H3 Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of Alzheimer's Disease. | Molecules | 2022 | 36615435 | PubTator, text mining | PubMed |
| Simultaneous Antagonism at H3R/D2R/D3R Reduces Autism-like Self-Grooming and Aggressive Behaviors by Mitigating MAPK Activation in Mice. | Int J Mol Sci | 2022 | 36613969 | PubTator, text mining | PubMed |
| Bioluminescent and Fluorescent Proteins: Molecular Mechanisms and Modern Applications. | Int J Mol Sci | 2022 | 36613724 | PubTator, text mining | PubMed |
| Current Pharmacotherapy and Multi-Target Approaches for Alzheimer's Disease. | Pharmaceuticals (Basel) | 2022 | 36559010 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11255/papers?page=10